AI-mediated ultrasound radiomics in the diagnosis and treatment of triple-negative breast cancer: research progress and future challenges - Takeaways - MDSpire

AI-mediated ultrasound radiomics in the diagnosis and treatment of triple-negative breast cancer: research progress and future challenges

  • By

  • Zhihe Wang

  • Yifan Wang

  • Tao Yu

  • Yan Yi

  • Ke Xue

  • Wei Xu

  • April 30, 2026

  • 0 min

Share

  • 1

    Triple-negative breast cancer (TNBC) is highly invasive, accounts for 15%-20% of breast cancers, and has limited treatment options and poor prognosis.

  • 2

    AI-enhanced ultrasound radiomics offers a non-invasive approach for diagnosing TNBC by extracting quantitative features from ultrasonic images.

  • 3

    Current AI models for TNBC diagnosis have improved from basic differential diagnosis to multi-subtype classification using multimodal image fusion.

  • 4

    Challenges in implementing AI-driven radiomics include insufficient standardized data protocols, limited model interpretability, and lack of multicenter validation.

  • 5

    Future research should focus on establishing standardized workflows and conducting multicenter studies to verify the clinical value of AI in TNBC management.

Original Source(s)

AI-mediated ultrasound radiomics in the diagnosis and treatment of triple-negative breast cancer: research progress and future challenges

  • by Zhihe Wang, Yifan Wang, Tao Yu, Yan Yi, Ke Xue, Wei Xu

  • April 30, 2026

Related Content

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison